January 07, 2016.
Brazil has approved Sanofi Pasteur’s new dengue vaccine Dengvaxia as a preventive tool.
Brazil's regulator ANVISA approved the vaccine to prevent all four types of dengue in people ages 9 to 45 in regions where the tropical disease is present. More than 1.4 million Brazilians were infected with the virus this outbreak season,.
Can Data and AI Deliver Whole-Person Health?
July 9th 2024Executives in the life sciences and medical device industries see promise in artificial intelligence (AI) and medical technologies, but must also navigate the changing healthcare ecosystem, varied stakeholder needs, and the impact of AI on market access and commercialization strategies.